This includes multiple case studies reported by our group, including biopsy findings that reinforce TMA as a pathognomonic lesion of VEGF blockade, with associated collapsing focal segmental glomerulosclerosis [5]. This evidence concerns the gene VEGFA and focal segmental glomerulosclerosis.